Revenue segments as reported by the company.

Revenues including Excise Taxes

Excise Taxes on products

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Amortization of intangibles

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Philip Morris

Malboro is an American brand of cigarettes, currently owned and manufactured by Philip Morris USA. It is sold globally and one of the most popular ciggarettes in the world.

Malboro

Philip Morris International, Inc. is a holding company, which engages in the business of delivering a smoke-free future and evolving a portfolio for the long term to include products outside of the tobacco and nicotine sector. It operates through the following geographical segments: Europe Region (Europe), South and Southeast Asia, Commonwealth of Independent States, Middle East, and Africa Region (SSEA, CIS, and MEA), East Asia, Australia, and PMI Duty Free Region (EA, AU, and PMI DF), and Americas Region (Americas). The Europe segment includes all the European Union countries, Switzerland, the United Kingdom, Ukraine, Moldova, and Southeast Europe. The SSEA, CIS, and MEA segment focuses on South and Southeast Asia, the African continent, the Middle East, Turkey, Israel, Central Asia, Caucasus, and Russia. The EA, AU, and PMI DF segment is involved in the consolidation of international duty-free business with East Asia and Australia. The Americas segment is comprised of the United States, Canada, and Latin America. The company was founded by Philip Morris in 1847 and is headquartered in Stamford, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Philip Morris excels in 2022, eyes growth through sustainability

Philip Morris navigated challenges in 2022 to deliver strong results and is poised for continued growth in 2023. By focusing on smoke-free products, sustainability, and strategic investments, PM is positioning itself for long-term success despite geopolitical and economic headwinds.

Philip Morris beats Q1 expectations with strong IQOS performance

Philip Morris delivered a strong Q1 performance driven by IQOS, ZYN, and combustibles.
Despite challenges like currency devaluation and volume declines, PMI remains optimistic.
Future opportunities lie in organic growth, commercial investments, and smoke-free product expansion.
Overall, PMI aims for continued growth in 2023 with a focus on key product lines.

Philip Morris (PM) reports record earnings, eyes growth in smoke-free products

Philip Morris International (PM) delivered strong financial performance in Q2 2023, driven by the success of ZYN and IQOS. The company is focused on maximizing the potential of its smoke-free business, particularly IQOS and ZYN, while addressing challenges in deleveraging the balance sheet and potential M&A. Opportunities for growth include expanding market presence for ILUMA and maintaining strong performance in combustibles.

Philip Morris reports strong Q3 earnings driven by smoke-free products

Philip Morris International's Q3 performance was robust, driven by smoke-free products like IQOS and ZYN. Despite challenges like inventory concerns and currency impacts, the company is focused on growth opportunities and investment in key markets. Strong outlook for organic income growth and continued focus on reduced-risk products.

Philip Morris excels in smoke-free products, eyes global expansion

Philip Morris delivered strong results in 2023, driven by smoke-free products. Despite challenges like currency impacts and regulatory concerns, the company aims for continued growth and market expansion.

Philip Morris (PM) surpasses Q1 expectations, faces currency challenges

Philip Morris (PM) delivered strong Q1 2024 results driven by IQOS and ZYN businesses, exceeding expectations across key financial metrics. The company faces challenges from currency headwinds, geopolitical factors, and supply chain tensions. Strategic pricing actions and market expansion present growth opportunities.

Philip Morris excels in Q2 2024 with strong product growth

Philip Morris' Q2 2024 performance showcased strong growth in key products and markets, with a focus on responsible marketing and growth strategies for smoke-free offerings. The company remains optimistic about future growth prospects despite challenges.

Philip Morris excels in Q3, raises guidance on strong performance

Philip Morris International Inc. reported exceptional Q3 results, surpassing expectations and demonstrating strong performance across its portfolio. Despite challenges such as supply constraints and illicit product concerns, the company remains focused on growth opportunities, including expanding production capacity and advancing sustainability efforts.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Philip Morris International Inc. reported second quarter net income totaling $2.17 billion, or $1.39 per share, up from $1.95 billion, or $1.25 per share last year. Adjusted EPS of $1.57 beat the FactSet consensus for $1.55.

Philip Morris reports revenue miss

NEW YORK--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (NYSE:PM) today announces its 2021 second-quarter results. Growth rates presented in this press release on an organic basis reflect currency-neutral underlying results. Adjusted net revenues exclude the impact related to the Saudi Arabia customs assessments. Adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures are included in the schedules to this press release. 2021 SE

Philip Morris International Inc. Reports 2021 Second-Quarter Reported Diluted EPS of $1.39—Including Charges for Saudi Arabia Customs Assessments and Exit Costs—and Adjusted Diluted EPS of $1.57, Reflecting Organic Growth of 17.8%

Philip Morris Intl (NYSE:PM) unveils its next round of earnings this Tuesday, July 20. Get prepared with Benzinga's ultimate preview for Philip Morris Intl's Q2 earnings.

Philip Morris Intl's Earnings: A Preview

Two purchases this month point this global cigarette company in a new direction.

This Tobacco Giant Wants You to Think It's a Healthcare Company Now

Halliburton

HCA Healthcare

With the first week of the June-quarter earnings season behind us, we are looking ahead to what the coming week has in store.

Earnings Previews: Halliburton, HCA, Philip Morris, Synchrony

Philip Morris (PM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for Philip Morris (PM) This Earnings Season?

Con Ed

Enbridge

Altria

The market keeps climbing to new highs, causing many investors to worry that no good bargains remain on Wall Street. Even with the market 30% overvalued, plenty of bargains are available, for any goal or risk profile, even among dividend aristocrats.

5 High-Yield Dividend Aristocrats That Could Double In 5 Years

Philip Morris' (PM) second-quarter 2021 results are likely to reflect solid pricing power and strength in reduced risk products. However, duty-free business is likely to show weakness.

Things Worth Noting Before Philip Morris' (PM) Q2 Earnings

Britain's business minister has tasked the government with keeping tabs on Marlboro maker Philip Morris International Inc's (NYSE: PM) proposed takeover of U.K-based inhalation-focused CDMO Vectura.  Business Minister Kwasi Kwarteng is working with officials to understand better Philip Morris' plans for Vectura, which develops therapies to treat some of the very lung diseases Philip Morris' products cause, The Times reported.

Vectura, Philip Morris $1.45B Deal Under UK Government Scrutiny: Times

Anti-smoking groups are urging the government to block the £927mln bid for respiratory drugs group Vectura Group PLC (LON:VEC) from tobacco giant Philip Morris International A host of lobby groups have complained to the government about the deal, the Times reported, including the Tobacco Control Research Group, which is a research partner in STOP, Cancer Research UK and Action on Smoking and Health (Ash). Medical research charities, meanwhile, are said the be “horrified” at the deal, reported the paper, and want the government to “work to ensure the future of this vital company is not in any way at risk”.

Government urged to block Vectura takeover by Philip Morris

British Business Minister Kwasi Kwarteng has asked officials to monitor drugmaker Vectura Group PLC's proposed takeover by U.S. tobacco group Philip Morris International Inc, the Times newspaper reported https://bit.ly/3efO4ag.

British minister asks for monitoring of Vectura's proposed takeover by Philip Morris -The Times

Philip Morris (PM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Philip Morris (PM) Earnings Expected to Grow: Should You Buy?

NEW YORK--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (NYSE: PM) will host a live audio webcast on www.pmi.com/2021Q2earnings on Tuesday, July 20, 2021, at 9:00 a.m. ET to discuss its 2021 Second-Quarter results, which will be issued at approximately 7:00 a.m. ET the same day. During the webcast, Emmanuel Babeau, Chief Financial Officer, will discuss PMI's results and answer questions from the investment community and news media. The webcast will be in a listen-only mode.

Philip Morris International Inc. to Host Webcast of 2021 Second-Quarter Results

For over 50 years, high-yield tobacco blue-chips have been rich retirement dream stocks. Philip Morris is the industry leader in reduced risk products and its official policy is that it wants to stop selling cigarettes in most countries within 10 to 15 years.

8 Reasons Philip Morris Is An Incredible High-Yield Rich Retirement Opportunity

American Airlines

Carnival

Discover

Goldman Sachs

JPMorgan Chase & Co

Stamps.com

Reopening stocks and financials were some of the day's biggest gainers.

Stock Market Today: Stocks Bounce Back to Hit New Highs

Marlboro cigarette maker Philip Morris International Inc. (NYSE: PM) announced Friday a deal that would give a further thrust to its "Beyond Nicotine" strategy. The Philip Morris-Vectura Deal Terms: New York-based Philip Morris said it has agreed with the board of Vectura Group plc (OTC: VEGPF) regarding an all-cash offer to buy the latter for an enterprise value of 852 million pounds or $1.2 billion.

Philip Morris To Buy UK Drug Company Vectura For $1.2B As Part Of 'Beyond Nicotine' Push

The purchase of inhaled medicine business Vectura PLC (LON:VEC) by tobacco giant Philip Morris International Inc (NYSE:PM) has sparked speculation about what other acquisitions could be on the cards for deep-pocketed tobacco titans or others in similarly non-ESG industries. Famous (or maybe infamous for some investors in these ESG days) for its Marlboro cigarette brand, tobacco giant PMI said it is snapping up the UK firm as part of grand plans to build a portfolio “beyond nicotine” and rather dubiously try and become a “broader healthcare and wellness company".

Marlboro maker's move into medicines could inspire big tobacco rush to diversify

PM agreed to acquire Vectura for $1.2bn this morning; including Fertin Pharma last week, PM has spent $2bn in the last 2 weeks.

Philip Morris: Reviewing Vectura And Fertin Pharma Acquisitions; Reiterate Buy

Philip Morris International Inc (NYSE: PM) said on Friday it will buy Vectura Group plc (LON: VEC) for £1.05 billion as part of its push to expand its products portfolio beyond nicotine. The Marlboro cigarette maker's deal translates to 150 pence per share in cash for Vectura stockholders – an 11% premium on the price […] The post Philip Morris to acquire British drugmaker Vectura for £1.05 billion appeared first on Invezz.

Philip Morris to acquire British drugmaker Vectura for £1.05 billion

Tobacco giant strikes deal for British firm developing pioneering inhaled treatment for Covid-19

Philip Morris International makes £1bn offer for UK pharma firm Vectura

Philip Morris International Inc. (NYSE:PM) has agreed to acquire Vectura Group PLC (LON:VEC) as part of “a natural evolution into a broader healthcare and wellness company”. It has offered 150p per share for Vectura, valuing the pharma group at £1bn.

Philip Morris swoops in for Vectura to become ‘broader healthcare and wellness company'

Cigarette maker Philip Morris International Inc said on Friday it will buy Vectura Group in a deal valuing the British pharmaceutical company at 1.05 billion pounds ($1.44 billion) as it expands beyond tobacco and nicotine.

UK's Vectura agrees to $1.44 billion rival bid from Philip Morris

NEW YORK--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has agreed with the board of Vectura Group plc (Vectura) (LSE: VEC) on the terms of an all-cash, recommended offer to acquire Vectura for an enterprise value of GBP 852 million1 (approximately USD 1.2 billion2). Under the terms of the acquisition, Vectura shareholders would be entitled to receive 150 pence per share, a 46% premium to the ex-dividend closing price per Vectura share of 103 pence on May

Philip Morris International Inc. Announces Firm Offer to Acquire Vectura Group plc; Acquisition Accelerates PMI's Beyond Nicotine Strategy and Expands its Product Pipeline Development Capabilities in Inhaled Therapeutics

Amgen

Amazon

Polaris

5 Amazing Blue-Chips That Could Soar 165% In 5 Years

Philip Morris (PM) is expected to complete the acquisition of Fertin Pharma by fourth-quarter fiscal 2021. The move is likely to help its innovation capabilities in the oral delivery platform.

News for Philip Morris Stock (PM)